Redefining treatment interval in lung cancer surgery in the era of prehabilitation: a systematic review.

ABSTRACT:

Background

Time-to-surgery is used as a surrogate quality indicator within lung cancer care. However, its definition is not clearly defined in the literature. This study aimed to explore the evidence on optimal time-to-surgery interval with no negative impact on disease progression or oncological outcomes.

Methods

A systematic search was performed in January 2025 through MEDLINE, EMBASE, and Cochrane databases. Studies about lung cancer patients with treatment interval description until surgery were included.

Results

Eighty-six studies were included with a clear definition of the treatment interval until surgery. Starting points of the interval varied widely, of which pathological diagnosis was reported most often. Thirty-six studies also included associations of time

SUBMITTER: Geomini LD 

PROVIDER: S-EPMC12683378 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature